The Universal Medication Schedule (UMS) | qualitative evaluation investigating feasibility of implementation in primary care
|Starts:||14:00 11 Feb 2014|
|Ends:||15:00 11 Feb 2014|
|What is it:||Academic calendar|
|Organiser:||Institute of Population Health|
|Speaker:||Dr Cassandra Kenning|
Host: Institute of Population Health
About the event:
Poor adherence to prescribed medication has significant consequences. It is estimated that 5-8% of hospital admissions in the UK are related to ineffective or inappropriate use of medicines. A Cochrane review concluded that improving medicines taking may have a far greater impact on clinical outcomes than an improvement in treatments. Issues related to poor adherence may be particularly important in patients with multimorbidity.
In the US, the ‘Universal Medication Schedule’ (UMS) – which includes a simple chart bringing all medicines in the regimen together over 4 dosing periods through the day and which also explains the purpose of each medication to improve understanding, has been developed. The UMS has been developed for use in the US care system and has not been evaluated as an intervention on its own, only in conjunction with simplification of prescription labels. Therefore, it was not clear if the results would be generalizable, feasible or acceptable to primary care practice in the UK.
The aim of this research was to explore the medicines-related needs and support of older patients with multiple long-term conditions, and ways in which pharmacists and GPs could collaboratively use the UMS within existing medicines review services to meet the needs of patients.
Dr Cassandra Kenning
Role: Research Associate
Organisation: Centre for Primary Care, Institute of Population Health, University of Manchester
Travel and Contact Information
Seminar Room 1, 5th Floor